NCT06950554

Brief Summary

This study investigated the test-retest reliability and construct validity of the i-TUG, standard TUG, and Berg Balance Scale (BBS) using the EncephaLog smartphone application in individuals with chronic ischemic stroke. A total of 49 participants were assessed in two sessions to evaluate test-retest reliability. Construct validity was analyzed using Pearson correlation coefficients. Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC) values were also calculated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 25, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2025

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

April 18, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 30, 2025

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

3 months

First QC Date

April 18, 2025

Last Update Submit

April 25, 2025

Conditions

Keywords

Stroke, Balance, Berg balance scale, Rehabilitation, EncephaLog

Outcome Measures

Primary Outcomes (3)

  • Instrumental Timed Up and Go Test (i-TUG) by EncephaLog

    The EncephaLog is an FDA-cleared, smartphone-based application designed to assess dynamic balance and gait disorders in older adults and individuals with neurological or non-neurological conditions. The application uses the smartphone' built-in accelerometer and gyroscope to deliver reliable and valid kinematic assessments.

    Day 1 and Day 7

  • Timed Up and Go Test (TUG)

    The TUG test is a commonly used and validated measure to assess balance and mobility. Initially developed for older adults, 29 it has since been widely adopted for neurological and pediatric populations. 30-32 The test requires the participant to rise from a chair, walk 3 meters, turn, return, and sit down. The time to complete the task is recorded. A score greater than 13.5 seconds indicates an increased risk of falling in elderly.

    Day 1 and Day 7

  • Berg Balance Scale (BBS)

    The BBS consists of 14 items designed to assess postural control and fall risk in elderly individuals. 35 Tasks include sitting to standing, standing unsupported, transfers, turning, and stepping. Each item is scored from 0 to 4, and the total score ranges from 0 to 56. A score between 0-20 indicates high fall risk and need for assistive devices; 21-40 indicates moderate fall risk; and 41-56 indicates low fall risk with no need for assistive devices.

    Day 1 and Day 7

Study Arms (1)

EncephaLog Assessment Group

The EncephaLog is an FDA-cleared, smartphone-based application designed to assess dynamic balance and gait disorders in older adults and individuals with neurological or non-neurological conditions. The application uses the smartphone' built-in accelerometer and gyroscope to deliver reliable and valid kinematic assessments.

Eligibility Criteria

Age18 Days - 75 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

ischemic stroke patients

You may qualify if:

  • voluntary participation, a diagnosis of stroke, no involvement in any physiotherapy program for at least three months prior to the study, age between 18 and 75 years, the ability to walk independently Functional Ambulation Scale (FAS) score greater than 3, and the spasticity of the m. gastrocnemius was graded as 2 or less on the Modified Ashworth Scale (MAS).

You may not qualify if:

  • Participants were excluded if they had severe visual or cognitive impairments, severe cardiovascular disease, or musculoskeletal conditions or skin disorders that affected the lower extremities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakif University

Istanbul, Eyupsultan, 34250, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Ischemic StrokeStroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RESEARCH ASSISTANT

Study Record Dates

First Submitted

April 18, 2025

First Posted

April 30, 2025

Study Start

November 25, 2024

Primary Completion

March 5, 2025

Study Completion

April 5, 2025

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

De-identified data (i-TUG, TUG, and BBS scores) will be available upon request after publication for research purposes.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
De-identified individual participant data and supporting documents (study protocol, statistical analysis plan, and analytic code) will be available beginning 6 months after publication and will remain available for 2 years.
Access Criteria
Qualified researchers affiliated with academic institutions will be able to request access to de-identified individual participant data (i-TUG, TUG, BBS scores), study protocol, statistical analysis plan, and analytic code. Requests should be submitted to the corresponding author and will be reviewed by the study team. Data will be shared via secure institutional data transfer platforms.

Locations